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The E1A oncogene of adenovirus type 5 induces susceptibility of mammalian cells to lysis by natural killer lymphocytes
(NK cells). It is unknown whether sensitization to NK killing is mediated directly by targeting effects of interactions between
E1A peptides and cell surface MHC molecules or indirectly by an E1A activity that requires structural integrity of the
oncoprotein. To discriminate between these hypotheses, rat and hamster cells expressing wild type E1A were contrasted
with those expressing truncated products resulting from E1A termination or deletion mutations. Transfected rat cells,
expressing truncated proteins from the E1A first exon that encodes MHC-binding peptides, remained resistant to lysis by
NK cells, whereas cells expressing full-length E1A protein were highly susceptible to lysis. Studies of infected hamster
cells showed that addition of either of two, nonoverlapping, second exon regions reconstituted cytolytic susceptibility
induction by E1A. The results do not support the E1A-peptide-MHC hypothesis, since no single E1A peptide coding region
was sufficient to convey cytolytic susceptibility to expresser cells. The data indicate that coordinate functions of the E1A
first exon and redundant accessory regions in the second exon are required for E1A-induced susceptibility to NK killing.
q 1996 Academic Press, Inc.
INTRODUCTION Cook, 1995). However, the mechanisms by which E1A
oncoproteins confer cytolytic susceptibility on cells are
There has been progress in understanding the mecha- unknown. For example, it is not known whether E1A me-
nistic role of oncogenes in neoplastic transformation of diates this change in cellular cytolytic phenotype directly
mammalian cells in vitro. However, there is limited knowl- by serving as a source of foreign antigen (Bellgrau et al.,
edge of how oncogenes positively or negatively influence 1988; Kast et al., 1989) that targets expresser cells for
the ability of transformed cells to form tumors in vivo. recognition and killing by NK cells (Chadwick et al., 1992)
One determinant of tumor development by DNA virus- or indirectly through one of its activities involving regula-
transformed cells in immunocompetent animals is the tion of cellular gene transcription (Kingston et al., 1985)
relative susceptibility of viral oncogene-expressing cells that either increases NK targeting or alters cellular resis-
to lysis by natural killer lymphocytes (NK cells) (Cook et tance to NK cell-induced injury.
al., 1982, 1983, 1993; Lewis and Cook, 1985; Sawada et One way to increase the susceptibility of cells to NK
al., 1985; Sheil et al., 1984; Walker et al., 1991). NK cells killing is to reduce either the expression (quantitative
are mononuclear inflammatory cells that appear early at effect) or the inhibitory activity (qualitative effect) of cell
sites of inflammation, infiltrate tumors, secrete cytokines, surface class I MHC antigens (Chadwick et al., 1992;
and spontaneously lyse tumor cells without prior sensiti- Ljunggren and Karre¨, 1990; Storkus et al., 1992). This
zation or specific activation (Kurosawa et al., 1993). inhibitory effect of class I molecules could be mediated
Therefore, these cells may provide an early defense by masking NK target structures (Storkus and Dawson,
against tumor development. 1991) or by providing an ‘‘off signal’’ through NK cell re-
Expression of the E1A oncogene of human adenovirus ceptors, analogous to the murine Ly-49 molecule (Yoko-
serotypes 2 and 5 (Ad2/5) actively induces virus-infected, yama, 1995). Studies of E1A-expressing, adenovirus (Ad)-
virus-transformed, and stably transfected mammalian transformed rodent cells have revealed no correlation
cells from several species to become highly susceptible between total MHC antigen expression level on cells and
to NK cell killing (Cook et al., 1986, 1987; Routes and the NK cytolytic phenotype (Cook et al., 1982; Haddada
et al., 1986; Routes and Cook, 1990, 1995). This suggests
that E1A-induced cytolytic susceptibility is not mediated1To whom reprint requests should be addressed. Fax: (303) 398-
by quantitative reduction of class I MHC expression on1806.
2Present address: Immunex Co., Seattle, WA 98101. Ad-transformed cells. The NK cell resistance of cells
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transformed by highly oncogenic Ad12 (Cook et al., 1982; 1979) from near-term, random-bred, Golden Syrian ham-
sters (National Jewish Center Animal Care Facility) andRaska and Gallimore, 1982) which express very low lev-
els of class I MHC antigens supports this conclusion. were used in cytolysis assays at the first or second tissue
culture passage. Transformed cell lines were maintainedRecent observations on the relationships between MHC
expression and inhibition of NK activity and on the in Dulbecco modified Eagle medium containing antibiot-
ics and supplemented with 5% calf serum (Hyclone, Ster-blocking effects of foreign, for example viral (Chadwick
et al., 1992), peptides on this MHC ‘‘off-signal’’ suggest ile Systems). HEC were maintained in the same medium
supplemented with 10% calf serum. Cell lines werean alternative, qualitative mechanism by which cellular
expression of viral genes such as E1A might influence tested for Mycoplasma contamination by the Mycotect
assay (Bethesda Research Laboratories) and were nega-the cellular cytolytic phenotype. For example, E1A pro-
teins might enhance the cytolytic susceptibility of ex- tive.
Viruses. The wild-type Ad5 deletion mutant, dl309 (for-presser cells by serving as an endogenous source of
such inhibitory, MHC-binding peptides. mal name H5dl309), contains a wild-type E1A gene
(Jones and Shenk, 1979). The Ad5 host range mutant,In the studies reported here, we directly tested the
E1A–peptide–MHC hypothesis by assessing the cyto- hr440 (formal name H5hr440), synthesizes a truncated
polypeptide of 140 amino acids encoded by sequenceslytic phenotypes of transfected rat cells and virally in-
fected hamster cells expressing products of the E1A first in the first E1A exon that are common to the E1A 13S
and 12S mRNAs; second exon E1A sequences are notexon or the first exon plus nonoverlapping regions of the
second exon, respectively. The E1A first exon, and not expressed (Solnick, 1981). The Ad5 E1A mutant, 12S.WT,
expresses only the 12S E1A mRNA product (Moran etthe second exon, encodes class I MHC-binding peptides
in Fischer rat cells (Routes et al., 1991). The results show al., 1986). The Ad5 mutant, dl530 (formal name H5dl530),
contains an E1A gene that synthesizes a truncated 192-that expression of the E1A first exon is insufficient to
confer susceptibility to NK cell-mediated lysis and that, amino-acid polypeptide of which the amino-terminal 185
residues are translated from the same E1A first exonin addition to the first exon, redundant activities of two
different regions of the E1A second exon are required reading frame as the E1A 12S and 13S mRNA products,
and the carboxyl-terminal 7 amino acids are translatedfor this activity. No single E1A peptide coding region was
sufficient for induction of cytolytic susceptibility. The data from an alternative reading frame (Schneider et al., 1987).
The Ad5 E1A mutants, 1267(0) and 1304(0), contain in-indicate that complementary interactions between the
two E1A exons are required for E1A to convert cytolytic frame termination codons which were inserted in the
E1A second exon at nucleotide positions 1267 and 1304,resistant cells to cells that are susceptible to NK cell
killing and infer that the mechanism by which E1A medi- respectively, and synthesize both 12S and 13S mRNA-
encoded proteins with C-terminal deletions of 91 and 79ates this cellular phenotypic change involves regulatory
actions of the intact E1A molecule. amino acids, respectively (Bautista et al., 1991). The Ad5
deletion mutant, dl975/1339, synthesizes a protein that
is translated only from the E1A 12S mRNA and is missingMATERIALS AND METHODS
the first 36 amino acids encoded by the N-terminal sec-
ond exon but contains all other second exon amino acidsCells and cell lines. Ras3 (formal name, BRKnras3) is
a Fischer strain cell line derived by immortalization of (Quinlan et al., 1988). All viruses were grown in 293 cells,
and titers of viral stocks were determined by plaquing insecondary baby rat kidney (BRK) cells by transfection
with the plasmid, pEJras, containing the activated ras 293 cells.
Cytolysis assays. Assays of NK cell killing of targetoncogene (Gly to Val, residue 12) derived from a bladder
carcinoma (Kelekar and Cole, 1987). A2T2C4 is an Ad2- cells were performed as described (Cook et al., 1987,
1989b), with minor modifications. Unprimed, adult (2- totransformed, Hooded Lister strain, rat embryo fibroblast
cell line (Gallimore, 1974). 9–3–3 is a Fischer strain baby 6-month-old), random-bred, golden Syrian hamsters (Na-
tional Jewish Center Animal Care Facility) and out-bred,rat kidney (BRK) cell line derived by cotransfection with
pEJras and a plasmid containing the E1A gene of the Sprague–Dawley rats (Banton-Kingman Laboratory) of
either sex were used as spleen cell donors for NK cellAd5 host range mutant, H5hr1, which expresses a wild-
type 12S mRNA and a truncated 13S mRNA due to a cytolysis assays. HEC were incubated at 377C for 24 hr
with the indicated viral inoculum and were simultane-base substitution at nucleotide 1055 (Zerler et al., 1986).
28–3–1, 28 – 3 – 2, and 28 –3–3 are Fischer strain rat cell ously radiolabeled with [3H]thymidine (0.5 mCi/ml, sp act
2.0 Ci/mmol). Virus-infected HEC were washed and co-lines derived by stable cotransfection of BRK cells with
pHrA and pT24 Ha-ras (Zerler et al., 1986). pHrA contains cultured (3 1 104 cells per well) with donor spleen cells
for 48 hr at an optimal 100:1 spleen cell-to-target cellthe Ad5 hr440 (see Viruses) E1A gene (Solnick, 1981),
and pT24 Ha-ras contains the activated (Val-12) human ratio in 48-well cluster plates (Costar 3548) in a total
volume of 1 ml. Transformed cells were radiolabeled withras oncogene (Franza et al., 1986). Hamster embryo cells
(HEC) were prepared as described (Cook and Lewis, 51Cr (100 mCi/ml for 45 min at 377C) for 18-hr assays or
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with [3H]thymidine (0.5 mCi/ml, overnight at 377C) for 48- To select pHrA/ras-transfected cells that expressed
high levels of E1A proteins, three rat cell lines (28–3–1,hr assays. Labeled, transformed cells were washed and
cocultured with spleen cells at various spleen cell-to- 28–3–2, 28–3–3) were compared to the cytolytic sus-
ceptible, E1A (243R) positive control cell line, 9–3–3, bytarget cell ratios (as indicated in the figures) in 96-well
plates (Costar 3596) in a total volume of 300 ml. All assays quantitative immunoprecipitation of lysates of [35S]methi-
onine-labeled cells using E1A-specific monoclonal anti-were performed in Dulbecco’s modified Eagle’s medium
containing Hepes (N-2-hydroxyethylpiperazine-N*-2-eth- body (Fig. 2A). All three cell lines of the 28–3 series
expressed detectable pHrA-encoded E1A proteins (Fig.anesulfonic acid) buffer (20 mM) and antibiotics and sup-
plemented with glucose (final concentration, 15 mM) and 2A, lanes 3–5). Of the three lines, 28–3–2 and 28–3–3
cells (Fig. 2A, lanes 4 and 5) expressed E1A truncated10% fetal bovine serum (HyClone). For each cytolysis
assay, target cell killing was determined by calculating protein at levels comparable to those observed with cyto-
lytic susceptible 9–3–3 cells (Fig. 2A, lane 2) as esti-the mean percentage of NK-cell-induced release of ra-
diolabel from triplicate cocultures as described (Cook et mated by band intensity. 28–3–2 and 28–3–3 may actu-
ally express higher steady-state levels of E1A proteinal., 1983). Data are presented as the mean { SEM of
the results from the indicated number of different assays. than 9–3–3 cells, since the pHrA E1A gene product con-
tains approximately half as many methionine residuesThe significance of the differences in the levels of NK
cell-induced cytolysis was estimated using Student’s t and therefore would be labeled less intensely than the
full-length, 243R E1A protein expressed by 9–3–3 cells.test.
Immunoprecipitations. Quantitative immunoprecipita- 28–3–2 cells were used to determine whether cyto-
lytic susceptibility can be induced by the E1A first exontion of E1A proteins from normalized lysates of cells la-
beled with [35S]methionine were done as described protein during stable oncogene transfection of cells. To
test this hypothesis, 28–3–2 cells were compared to(Cook et al., 1989a) using the E1A-specific monoclonal
antibody, M37, which recognizes an epitope in the N- control cells (9–3–3, susceptible control; ras-3, resistant
control) as targets in NK cytolysis assays (Fig. 2B). Interminus of the E1A protein (Harlow et al., 1985).
contrast to cytolytic susceptible, 9–3–3 cells, 28–3–2
RESULTS cells were resistant to NK killing in short-term (8 hr) cytol-
ysis assays (Fig. 2B, top). Prolonged periods of cocultiva-E1A first exon expression in transformed rat cells does
not induce cytolytic susceptibility. Our previous studies tion of NK cells with their targets can increase killing
due to cytokine-dependent activation of the killer cells,showed that the E1A first exon encodes the immunodom-
inant E1A peptides that bind Fischer rat class I MHC killer cell recycling, and increased detection of lytic
mechanisms (e.g., tumor necrosis factor-alpha) that ex-antigens (Routes et al., 1991). We also reported that E1A-
induced susceptibility of target cells to killing by NK cells hibit delayed kinetics of cytolysis (Ortaldo, 1986). There-
fore, to increase the sensitivity of these cytolysis assaysis dependent on high level expression of endogenous
E1A proteins in both transfected (Cook et al., 1989a, for detecting marginal levels of cytolytic susceptibility
induced by the E1A first exon-encoded protein, longer1993) and virally infected (Cook et al., 1987) rodent cells.
Therefore, to test the hypothesis that E1A–peptide–MHC cytolysis assays were used. After 18 and 48 hr of coculti-
vation (Fig. 2B, middle and bottom, respectively), 28–3–interactions are responsible for increased NK cytolytic
susceptibility, we assessed the cytolytic phenotypes of 2 cells remained highly resistant to NK killing. These
data show that the E1A first exon protein (and the associ-Fischer rat cells expressing high levels of E1A first exon
proteins. ated MHC-binding E1A peptides) expressed at levels
comparable to or exceeding those seen with wild-typeRat cell lines derived by cotransformation with the
pHra plasmid (that contains only E1A first exon se- E1A protein expression does not induce cytolytic suscep-
tibility when stably expressed in Fischer rat cells. In lightquences; Fig. 1) and the activated ras oncogene (Zerler et
al., 1986) provided several advantages for these studies. of reported information mapping the coding regions for
Fischer, class I-binding E1A peptides to the E1A firstFirst, ras cotransfection with E1A favors high level E1A
expression in transformed cell lines (Zerler et al., 1986). exon, these data do not support the hypothesis that E1A
peptides eliminate the MHC ‘‘off signal’’ to NK killing and,Second, ras expression neither independently increases
the susceptibility of Fischer rat cells to NK cell killing nor thereby, increase cellular cytolytic susceptibility.
E1A first exon overexpression during viral infectioninhibits cytolytic susceptibility induction by E1A (Cook et
al., 1989b). Third, we had observed that the pHrA/ras does not induce cytolytic susceptibility. The alternative
to the hypothesis that E1A directly induced increasedcotransfected Fischer rat cell lines to be tested ex-
pressed E1A-first-exon-encoded peptides bound to cell cytolytic susceptibility through E1A peptide–MHC inter-
actions was that one or more activities of the intact E1Asurface class I MHC antigens, as evidenced by priming
of and targeting for killing by E1A-specific cytotoxic T molecule indirectly mediated conversion of cytolytic re-
sistant cells to cytolytic-susceptible targets of NK killing.lymphocytes (D. Bellgrau and J. L. Cook, unpublished
observations). Our reported observation that Ad infection of hamster
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FIG. 1. Schematic representation of the 243R (12S mRNA) and 289R (13S mRNA) Ad5 E1A proteins and protein products of E1A gene mutants
used in this study. (A) The translated polypeptides are shown as open bars. E1A conserved regions (1, 2, and 3) are indicated by shaded areas.
The black region at the carboxyl terminus of the dl530 product represents a region that is translated out of frame. The names of the E1A mutants
are listed in the column to the left. The numbers above each bar indicate the amino acid positions in the 289R protein. The total number of amino
acid residues of each gene product is listed in parentheses to the right. (B) Representation of the amino acid sequence encoded by the E1A second
exon, with the residue positions relative to the 289R E1A protein denoted above.
and rat embryo fibroblasts can be used to study E1A- tion to these studies, we tested the effect of high level E1A
first exon expression on the cytolytic phenotype of virallyinduced cytolytic susceptibility (Cook et al., 1987) pro-
vided a method by which to test the effects of different infected cells. HEC were infected with hr440, the Ad5 mu-
tant virus from which the pHrA E1A gene was isolated (Fig.E1A mutations on this cellular phenotypic change and to
compare the genetic requirements with those reported 1; Solnick (1981)). Hr440 was derived from wild-type dl309
virus, which expresses both 243R and 289R E1A oncopro-for other E1A activities. Furthermore, the use of unse-
lected populations of virally infected, E1A-positive rodent teins. Therefore, dl309, which efficiently induces cytolytic
susceptibility in infected rodent cells (Cook et al., 1987), wascells addressed theoretical limitations of the interpreta-
tion of studies of E1A expressing, oncogene-transformed used as the positive control virus for these experiments. To
allow for adjustment of E1A protein expression to highcells. For example, using the single, transformed cell line,
28–3–2 (Fig. 2), it could not be excluded that the failure levels in infected cells, the relative expression of mutant
and wild-type E1A proteins was determined by quantitativeof E1A first exon protein to induce cytolytic susceptibility
could be explained by adventitious E1A gene or chromo- immunoprecipitation of [35S]methionine-labeled E1A pro-
teins from extracts of HEC infected at various m.o.i. Thesomal mutations acquired during transfection and clonal
selection. Another advantage of viral infection over onco- hr440 E1A first exon products were expressed at much
lower levels than the full-length E1A proteins synthesizedgene cotransformation of cells was the ability to manipu-
late cellular expression levels of different E1A mutant by dl309 in HEC infected at a m.o.i. of 100 (Fig. 3B, lane 3
vs lane 2, respectively). However, HEC infected with hr440proteins by altering the m.o.i. Ad-infected hamster em-
bryo cells (HEC) were chosen as targets for these virus at m.o.i.s of 200 and 1000 expressed increasing levels of
the E1A first exon-encoded oncoproteins (Fig. 3B, lanes 4infection studies, since HEC are relatively more permis-
sive than rat embryo cells for infection and E1A expres- and 5) that were equal to or greater than the levels of wild-
type E1A oncoproteins expressed in HEC infected withsion by a variety of mutant Ad strains. Hamster NK cell
assays were used to test the cytolytic phenotypes of HEC dl309 at a m.o.i of 100 (Fig. 3B, lane 2; again considering
the differences in protein labeling related to differences ininfected with wild type or mutant virus.
To extend the correlation between E1A-induced cytolytic the numbers of methionine residues encoded).
To determine whether the 140-amino-acid polypeptidesusceptibility during both stable transfection and viral infec-
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FIG. 2. High-level expression of the E1A first exon is not sufficient for cytolytic susceptibility induction in E1A/ras immortalized BRK cells. (A)
Comparison of the levels of E1A oncoprotein expression in BRK cells immortalized by pHrA/ras (28–3–1, 28–3–2, 28–3–3) and E1A 12S/ras
(9 –3–3). Cells immortalized by ras alone (ras-3) were used as an E1A negative control. Bands represent the results of quantitative immunoprecipitation
of radiolabeled, pHrA proteins (two major bands above the 18 kDa marker) or E1A 243R (12S) proteins (two major bands below the 43-kDa marker).
28 –3–1 expressed low levels of pHrA proteins, whereas 28–3–2 and 28–3–3 expressed pHrA protein levels equal to or greater than the level of
E1A 243R (12S) products expressed by 9–3–3 cells. (B) Comparison of the susceptibilities to lysis by rat NK cells of BRK cells immortalized by
pHrA/ras (28– 3–2), E1A 12S/ras (9–3–3), or ras alone (ras-3) in 8-, 18-, and 48-hr cytolysis assays. A2T2C4 cells express both the 243R and
289R E1A oncoproteins and were used as cytolytic susceptible controls in 48-hr assays. 9–3–3 cells express the 243R E1A protein, and 28–3 –2
cells express the N-terminal 140 amino acids of the 289R E1A protein. 9–3–3, 28–3–2, and ras-3 all express the p21ras oncoprotein. The results
represent the mean ({SEM) of at least three rat NK cell cytolysis assays. 28–3–2 were significantly less susceptible to lysis by rat NK cells than
9 –3 –3 or A2T2C4 (P  0.005), irrespective of the length of the cytolysis assay.
encoded by the pHrA E1A gene is capable of rendering another ‘‘first exon only’’ virus, dl530, confirmed the obser-
vations with hr440-infected target cells. dl530 producesvirally infected primary cells susceptible to NK cell killing,
the susceptibilities of HEC infected with 100, 200, or 1000 a truncated 192-amino-acid polypeptide of which the N-
terminal 185 amino acids are encoded by the E1A firstPFU per cell of hr440 virus or with 100 PFU per cell of
dl309 virus were determined in 48-hr NK assays. Despite exon (Fig. 1) (Schneider et al., 1987). In contrast to hr440
which expresses the E1A first exon sequences that en-expressing higher steady-state levels of truncated E1A
proteins, HEC infected with hr440 at m.o.i. of 200 or 1000 code the 243R (12S) product, dl530 expresses the equiva-
lent of the first exon of the 289R product, including E1Aremained highly resistant to lysis by NK cells (Fig. 3A).
The lack of a dose–response effect of the E1A first exon conserved region 3 (CR3) (Fig. 1). CR3 is not required for
induction of cytolytic susceptibility during either stablegene product on cytolytic susceptibility induction con-
trasts with our reported demonstration of the existence transfection or viral infection (Cook et al., 1986, 1987).
The protein expression data in Fig. 3B show that HECof such a dose–response relationship between wild-type
E1A protein expression and induction of this phenotype infected with dl530 at m.o.i.s of 100 or 200 expressed
low, steady-state levels of truncated E1A protein whenin infected cells (Cook et al., 1987).
Studies of the cytolytic phenotype of HEC infected with compared to dl309-infected HEC. However, at a m.o.i. of
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with either hr440 or dl530 supported the conclusion from
studies of E1A-immortalized rat cells (Figs. 2A and 2B)
that high level expression of the E1A first exon protein
does not induce cytolytic susceptibility and argued
against the possibility that the cytolytic resistance of 28–
3–2 cells might be explained by adventitious mutations
or clonal selection. Cumulatively, the results demon-
strated that the protein encoded by the E1A first exon
lacked the ability to induce cytolytic susceptibility under
conditions of both stable transfection and viral infection
and suggested the additional requirement for E1A sec-
ond exon expression for this cellular, phenotypic conver-
sion.
Addition of nonhomologous regions of the E1A second
exon to the first exon restores cytolytic susceptibility in-
duction activity. Of the E1A activities that require expres-
sion of the second exon, some have been mapped to
specific sequences. To determine whether cytolytic sus-
ceptibility induction by E1A depends on expression of a
specific second exon sequence, HEC infected with vi-
ruses expressing E1A genes with nonoverlapping re-
gions of the second exon (Fig. 1) were tested for suscep-
tibility to NK cell killing (Fig. 4A). The 1267(0) and 1304(0)
viruses express truncated versions of both E1A 243R
(12S) and 289R (13S) proteins, whereas dl975/1339 was
constructed on a ‘‘12S-only’’ E1A background. The re-
spective, parental, wild-type viruses, dl309 (control for
1267[0] and 1304[0]) and 12S.WT (Moran et al., 1986)
FIG. 3. High-level expression of the E1A first exon is not sufficient (which expresses only the E1A 12S product; control for
for cytolytic susceptibility induction in virally infected HEC. (A) Compari- dl975/1339), were used as positive control viruses for
son of the cytolytic susceptibilities of HEC infected with dl309, hr440,
these studies. Both the wild-type E1A 12S (243R) andor dl530. Bars represent the results (mean { SEM) of at least three
E1A 13S (289R) mRNA products induce expression-level-hamster NK cell cytolysis assays, done at the optimal spleen-cell-to-
dependent cytolytic susceptibility in infected cells (Cooktarget cell ratio of 100:1. The relative susceptibilities of HEC infected
with 100 PFU/cell of dl309 or HEC infected with 100, 200, or 1000 PFU/ et al., 1987). For the present studies, virally infected cells
cell of hr440 or dl530 to lysis by hamster killer cells were measured were tested for E1A protein expression at different m.o.i.
in 48-hr cytolysis assays. HEC infected with 100, 200, or 1000 PFU/cell
to ensure that any observed lack of induction of cytolyticof hr440 or dl530 were significantly less susceptible to lysis by hamster
susceptibility was not caused by inadequate E1A mutantNK cells than dl309-infected HEC (P0.005). (B) Comparison of E1A
protein expression (e.g., see Fig. 4B).oncoprotein expression levels by HEC infected with dl309, hr440, or
dl530. Bands represent the results of quantitative immunoprecipitation In contrast to the lack of cytolytic susceptibility of
of radiolabeled, E1A proteins from HEC infected overnight with the dl530-infected cells (Fig. 3), HEC infected with 1267(0)
indicated m.o.i. Dl309 infection was done at a m.o.i. of 100. HEC in-
or 1304(0), which express the E1A 13S (289R) first exonfected with hr440 and dl530 exhibited a m.o.i.-dependent increase in
plus the first 12 or 24 residues, respectively, encoded byexpression of truncated E1A proteins, such that cells infected with a
the E1A second exon (Fig. 1), were significantly morem.o.i. of 1000 expressed E1A protein levels exceeding those of dl309-
infected HEC. susceptible to NK killing than mock-infected cells (Fig.
4A). These data suggested the possibility that the proxi-
mal part of the E1A second exon encoded critical resi-
1000, the steady-state level E1A first exon protein ex- dues (e.g., the first 12 second exon residues present in
pressed in dl530-infected HEC was equal to or greater 1267[0]; Fig. 1) required to complement the first exon
than the level of wild-type E1A proteins in HEC infected polypeptide for E1A induction of the cytolytic susceptible
with dl309 at a m.o.i. of 100. (Again it is noted that dl530 phenotype. However, studies with the viral mutant, dl975/
E1A protein contains approximately half the number of 1339 (Fig. 1), indicated that these proximal second exon
methionine residues present in full-length E1A proteins.) residues were not unique in this respect. Infection of
Like pHrA/ras cotransfected rat cells (Fig. 2B) and HEC with dl975/1339 also induced cytolytic susceptibility
hr440-infected HEC, dl530-infected HEC (m.o.i.  1000) comparable to that observed with cells infected with the
remained resistant to NK cell killing (Fig. 3A). wild type control virus, dl309. These data showed that
nonoverlapping amino-terminal (1267[0]) and carboxy-These data on the cytolytic resistance of HEC infected
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the second exon regions can serve this function (e.g.,
compare amino acids 186–197 from 1267[0] to amino
acids 221–289 from dl975/1339 in Fig. 1B).
DISCUSSION
The ‘‘missing-self’’ hypothesis of NK cell recognition
of target cells states that, when NK cells interact with
complexes of self peptides and class I MHC antigens
on target cell surfaces, the NK cells receive signals that
inhibit their cytolytic activity (Karre¨, 1985; Ljunggren and
Karre¨, 1990). It is proposed that replacement of self pep-
tides in these complexes with foreign peptides, such as
those encoded by viral genes (Chadwick et al., 1992),
allows NK cell recognition and lysis of target cells by
altering the balance between NK cell stimulatory and
inhibitory signals. The class I MHC molecular sites re-
quired to inhibit both human and rodent NK activity are
antigen binding sites in the extracellular alpha1/alpha2
domains of class I molecules (Sentman et al., 1994;
Storkus et al., 1989). To displace self peptides, it appears
that foreign peptides must be 8 to 11 amino acids in
length and have specific affinity for these antigen binding
FIG. 4. Expression of the E1A first exon plus different second exon sites (Germain and Margulies, 1993). Most studies have
regions restores cytolytic susceptibility induction in virally infected used addition to the extracellular environment of foreign
HEC. (A) Comparison of the cytolytic susceptibilities of HEC infected
peptides previously shown to interact with one or morewith dl309, 1267(0), 1304(0), or dl975/1339. The relative susceptibilities
cell surface, MHC class I restricting elements. Underof HEC infected with 100 PFU/cell of dl309 or 1267(0) and HEC infected
with 400 PFU/cell of 1304(0), 12S.WT, or dl975/1339 to lysis by hamster pathological conditions, class I-MHC-binding peptides
killer cells were measured in 48-hr cytolysis assays. All infected cell are generated by cellular processing of foreign proteins
types were significantly more susceptible to lysis by hamster NK cells expressed intracellularly. Peptides that produce antigen-
than mock-infected HEC (P 0.01). (B) Comparison of E1A oncoprotein
specific, class-I-MHC-restricted cytotoxic T lymphocyteexpression levels in HEC infected with dl309, 1304(0), 1267(0), or
recognition also increase NK sensitivity of target cellsdl975/1339. E1A bands (indicated by brackets) represent the results of
quantitative immunoprecipitation of radiolabeled, E1A proteins from without affecting the level of total class I MHC expression
HEC infected overnight with dl309, 1304(0), 1267(0), or dl975/1339 at on the cell surface (Storkus et al., 1992). Peptides that
m.o.i.s of 100. cannot bind class I MHC antigen binding sites are inef-
fective in increasing NK sensitivity.
The E1A first exon encodes the immunodominant,terminal (dl975/1339) E1A second exon sequences could
complement the E1A first exon for conversion of the cyto- class I-MHC-binding peptides in Fischer strain rats
(Routes et al., 1991; Bellgrau and Cook, unpublished ob-lytic phenotype of expresser cells (Fig. 4A).
The results indicated that there was no specific se- servations). In the present study, E1A first exon expres-
sion in stably transfected Fischer rat cells did not in-quence requirement for restoration by the second exon of
the ability of E1A to induce cytolytic susceptibility. Another crease sensitivity to NK killing. In contrast, Fischer cells
expressing the full-length, 243R product encoded by bothinterpretation of this lack of specificity of E1A second exon
complementation of the first exon was that the second E1A exons exhibited high-level susceptibility to NK killing
(Fig. 2). Therefore, E1A first exon encoded peptides thatexon requirement could be fulfilled by non-E1A se-
quences. However, comparison of the results obtained bind Fischer class I MHC antigens do not enhance ex-
presser cell susceptibility to killing by NK cells. The E1Awith dl530 and 1267(0) suggested that this hypothesis
may be incorrect. In addition to the 185 amino acids of the second exon—which does not encode Fischer class
I-MHC-binding peptides (Routes et al., 1991)—is alsoE1A (289R) first exon, dl530 encodes 7 additional residues
translated out of frame (Fig. 1), and dl530 failed to induce required. These data do not support the E1A–peptide–
MHC hypothesis of E1A-induced cytolytic susceptibility.cytolytic susceptibility in infected cells (Fig. 3A). In contrast
to dl530, 1267(0), which adds the first 12 residues of the Studies of the effects of different E1A second exon
mutations on induction of cytolytic susceptibility in Ad-E1A second exon to the first exon, induced high-level
cytolytic susceptibility. This contrast suggested the con- infected hamster cells allowed examination of correla-
tions between the genetic requirements for induction ofclusion that the second exon requirement is in fact E1A-
specific, despite the fact that nonhomologous regions of this phenotype and other E1A activities. In the context of
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a host inflammatory response to E1A expressing neo- of residues (aa 185–220) identified by Velcich and Ziff
(1988) that is required for E1A-induced transcriptional re-plastic cells, it has been reported that E1A sensitizes
rodent cells to the cytotoxic effects of tumor necrosis pression. Similarly, the critical difference between the E1A
mutation of hr440 that did not induce cytolytic susceptibil-factor alpha (TNF) (Ames et al., 1990; Chen et al., 1987;
Cook et al., 1989a; Duerksen-Hughes et al., 1989), a pro- ity (Fig. 3) and dl975/1339 that induced cytolytic suscepti-
bility comparable to wild type virus (Fig. 4) is the additioninflammatory cytokine, and that another cytokine, in-
terleukin-1 (IL-1), increases the sensitivity of E1A ex- to the 243R (12S) coding region, in dl975/1339, of the
carboxyl-terminal 69 residues of the E1A second exon (aapressing cells to TNF (Tsuji et al., 1993). It may be rele-
vant to the present study that the E1A second exon is 223–289; Fig. 1). These residues include ‘‘auxiliary region
2’’ (aa 223–245) of Bondesson et al. (1992) that is requirednecessary for this IL-1-mediated augmentation of TNF
cytotoxicity, since TNFa and IL-1 are cytotoxic factors for E1A-induced transcriptional activation. Mymryk and
Bayley (1993) reported that the E1A second exon maysecreted by NK cells (Chong et al., 1989; Ortaldo, 1989).
E1A second exon sequences can also affect E1A-in- independently (i.e., without the first exon) transactivate
other genes. However, the possibility that the E1A secondduced modulation of cellular gene transcription. Such
transcriptional regulatory effects could be involved in the exon independently induces cytolytic susceptibility in the
assays reported here is unlikely, since the hypotheticalpostulated, indirect mechanism(s) by which E1A induces
cytolytic susceptibility of expresser cells. E1A-induced ‘‘second-exon-only’’ function would have to be mediated
by as little as the amino-terminal 12 residues encoded byrepression of transcription of genes activated by viral
and cellular enhancers requires expression of both E1A 1267(0) virus (Figs. 1 and 4). It cannot be formally ex-
cluded that the E1A second exon function described byconserved region 1 (Fig. 1; (Schneider et al., 1987; van
Dam et al., 1989)) and accessory regions in the second Mymryk and Bailey (1993) could affect the cellular cytolytic
phenotype through a mechanism that is redundant withexon. Velcich and Ziff (1988) reported that E1A first exon
expression in the absence of either the entire second that characterized here for interactive regions in the first
and second exons.exon or the first 16 residues of the second exon does
not repress transcription activated by the polyoma virus These data, viewed in the context of the current under-
standing of interactions between NK cells and their eu-enhancer. They concluded that the amino-terminus of the
E1A second exon may collaborate with the first exon to karyotic targets, suggest a modified hypothesis of the
mechanisms of action by which E1A oncogene expres-maintain the proper configuration of the E1A molecule
for transrepresser activity. Similar conclusions were sion indirectly induces the cellular phenotypic switch to
cytolytic susceptibility. The similarities of the E1A map-reached by Bautista et al. (1991) from studies of E1A-
induced transrepression of the E1A enhancer and by ping data presented here and those reported for known
transcriptional regulatory activities of this viral oncogeneLinder et al. (1992) from studies of E1A-induced transre-
pression of the cellular stromelysin gene. Comparison of suggest the existence of one or more functional domains
(other than CR3) in the E1A first exon which, in collabora-the E1A mapping results in the latter two reports sug-
gests that different E1A second exon regions may be tion with different E1A second exon regions, affect cellu-
lar gene expression, resulting in enhanced cellular sus-required to complement E1A conserved region 1 for
transrepression depending upon the enhancer tested. ceptibility to killing by NK cells. The results of our studies
of the effects of E1A first exon mutations on induction ofStudies by Bondesson et al. (1992) indicate that, as with
E1A-induced transcriptional repression, E1A-induced susceptibility to NK killing of tumor cells in vitro and of
their rejection by immunocompetent animals support thistranscriptional activation of other genes can also require
collaborative interactions between two E1A gene re- hypothesis (Cook et al., manuscript in preparation). There
are two general categories of mechanisms by which E1Agions, including different second exon ‘‘auxiliary regions.’’
Comparison of these reported E1A mapping data with effects on cellular gene expression might increase cyto-
lytic susceptibility. E1A could affect expression of a cellu-those presented in this report suggests an alternative type
of mechanism through which E1A induces cytolytic sus- lar gene (or genes) that alter cell surface expression of
target structures, the net effect of which is to stimulateceptibility—alteration of cellular gene transcription. The
critical difference between the E1A mutation in dl530 that NK cell lytic activity. Alternatively, E1A could modulate
expression of a cellular gene (or genes) that functionsdid not induce cytolytic susceptibility (Fig. 3) and 1267(0)
that induced cytolytic susceptibility comparable to wild at a postrecognition stage in the interaction between
NK cells and target cells to render target cells moretype virus (Fig. 4) is the addition to the first exon of the
289R (13S) coding region, in 1267(0), of the amino-termi- susceptible to lysis. Studies are in progress to discrimi-
nate among these mechanisms.nal 12 residues (aa 186–197) of the E1A second exon
(Fig. 1). These 1267(0) second exon residues overlap the
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